Work

MCL-341 Glofitamab Monotherapy In Patients With Heavily Pretreated Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Updated Analysis From A Phase 1/2 Study

Year: 2024

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(24)01600-8

Authors: Tycel Phillips, Carmelo Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Michael Crump, Marek Trněný, Nancy L. Bartlett, Jan Zaucha, Tomasz Wrobel, Fritz Offner, Audrey Filézac de L'Etang, James Relf, David J. Carlile, Ben Byrne, Estefania Mulvihill, Linda Lundberg, Michael Crump

Institutions: City Of Hope National Medical Center, Humanitas University, IRCCS Humanitas Research Hospital, Centre Hospitalier Universitaire de Lille, Hospices Civils de Lyon, Peter MacCallum Cancer Centre, Charles University, Washington University in St. Louis, Alvin J. Siteman Cancer Center, Gdańsk Medical University, Wroclaw Medical University, Ghent University Hospital, Roche (United Kingdom), Roche (Switzerland)

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4401877445

Cites:

Cited by: 1

Related to: 10